These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 27030010)
21. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo. Grace MS; Lieu T; Darby B; Abogadie FC; Veldhuis N; Bunnett NW; McIntyre P Br J Pharmacol; 2014 Aug; 171(16):3881-94. PubMed ID: 24779362 [TBL] [Abstract][Full Text] [Related]
22. Regulation of PKD1-mediated Golgi to cell surface trafficking by Gαq subunits. Coria AS; Masseroni ML; Díaz Añel AM Biol Cell; 2014 Jan; 106(1):30-43. PubMed ID: 24175919 [TBL] [Abstract][Full Text] [Related]
23. G protein betagamma complex translocation from plasma membrane to Golgi complex is influenced by receptor gamma subunit interaction. Akgoz M; Kalyanaraman V; Gautam N Cell Signal; 2006 Oct; 18(10):1758-68. PubMed ID: 16517125 [TBL] [Abstract][Full Text] [Related]
24. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. Déry O; Thoma MS; Wong H; Grady EF; Bunnett NW J Biol Chem; 1999 Jun; 274(26):18524-35. PubMed ID: 10373461 [TBL] [Abstract][Full Text] [Related]
25. Gγ identity dictates efficacy of Gβγ signaling and macrophage migration. Senarath K; Payton JL; Kankanamge D; Siripurapu P; Tennakoon M; Karunarathne A J Biol Chem; 2018 Feb; 293(8):2974-2989. PubMed ID: 29317505 [TBL] [Abstract][Full Text] [Related]
26. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4. Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282 [TBL] [Abstract][Full Text] [Related]
27. G-protein βγ subunits as multi-functional scaffolds and transducers in G-protein-coupled receptor signaling. Smrcka AV; Fisher I Cell Mol Life Sci; 2019 Nov; 76(22):4447-4459. PubMed ID: 31435698 [TBL] [Abstract][Full Text] [Related]
28. Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure. Casey LM; Pistner AR; Belmonte SL; Migdalovich D; Stolpnik O; Nwakanma FE; Vorobiof G; Dunaevsky O; Matavel A; Lopes CM; Smrcka AV; Blaxall BC Circ Res; 2010 Aug; 107(4):532-9. PubMed ID: 20576935 [TBL] [Abstract][Full Text] [Related]
29. G protein γ (Gγ) subtype dependent targeting of GRK2 to M3 receptor by Gβγ. Samaradivakara S; Kankanamge D; Senarath K; Ratnayake K; Karunarathne A Biochem Biophys Res Commun; 2018 Sep; 503(1):165-170. PubMed ID: 29864421 [TBL] [Abstract][Full Text] [Related]
30. p24A, a type I transmembrane protein, controls ARF1-dependent resensitization of protease-activated receptor-2 by influence on receptor trafficking. Luo W; Wang Y; Reiser G J Biol Chem; 2007 Oct; 282(41):30246-55. PubMed ID: 17693410 [TBL] [Abstract][Full Text] [Related]
31. Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits. Alkhatib O; da Costa R; Gentry C; Quallo T; Bevan S; Andersson DA J Neurosci; 2019 Oct; 39(40):7840-7852. PubMed ID: 31451581 [TBL] [Abstract][Full Text] [Related]
32. Regulation of G-protein signaling by RKTG via sequestration of the G betagamma subunit to the Golgi apparatus. Jiang Y; Xie X; Zhang Y; Luo X; Wang X; Fan F; Zheng D; Wang Z; Chen Y Mol Cell Biol; 2010 Jan; 30(1):78-90. PubMed ID: 19884349 [TBL] [Abstract][Full Text] [Related]
34. Receptor-mediated reversible translocation of the G protein betagamma complex from the plasma membrane to the Golgi complex. Akgoz M; Kalyanaraman V; Gautam N J Biol Chem; 2004 Dec; 279(49):51541-4. PubMed ID: 15448129 [TBL] [Abstract][Full Text] [Related]
35. Regulation of Golgi structure and secretion by receptor-induced G protein βγ complex translocation. Saini DK; Karunarathne WK; Angaswamy N; Saini D; Cho JH; Kalyanaraman V; Gautam N Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11417-22. PubMed ID: 20534534 [TBL] [Abstract][Full Text] [Related]
36. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599 [TBL] [Abstract][Full Text] [Related]
37. Contributions of protein kinases and β-arrestin to termination of protease-activated receptor 2 signaling. Jung SR; Seo JB; Deng Y; Asbury CL; Hille B; Koh DS J Gen Physiol; 2016 Mar; 147(3):255-71. PubMed ID: 26927499 [TBL] [Abstract][Full Text] [Related]
38. A new mode of Ca2+ signaling by G protein-coupled receptors: gating of IP3 receptor Ca2+ release channels by Gbetagamma. Zeng W; Mak DO; Li Q; Shin DM; Foskett JK; Muallem S Curr Biol; 2003 May; 13(10):872-6. PubMed ID: 12747838 [TBL] [Abstract][Full Text] [Related]
39. PKCeta is required for beta1gamma2/beta3gamma2- and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus. Díaz Añel AM; Malhotra V J Cell Biol; 2005 Apr; 169(1):83-91. PubMed ID: 15824133 [TBL] [Abstract][Full Text] [Related]
40. Role of the V2R-βarrestin-Gβγ complex in promoting G protein translocation to endosomes. Sokrat B; Nguyen AH; Thomsen ARB; Huang LY; Kobayashi H; Kahsai AW; Kim J; Ho BX; Ma S; Little J; Ehrhart C; Pyne I; Hammond E; Bouvier M Commun Biol; 2024 Jul; 7(1):826. PubMed ID: 38972875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]